Cancer of the pancreas is one of the most challenging malignancies to treat successfully.
While not as common as other cancers—such as colorectal, breast, prostate, and lung cancers—it is actually the fourth leading cause of cancer death among men and women in the United States. That’s because in most cases, it is inoperable or has already spread by the time it is diagnosed. At John Theurer Cancer Center, part of Hackensack University Medical Center in New Jersey, patients with pancreatic cancer receive comprehensive care to treat the disease while maintaining their quality of life as much as possible.
Our Gastrointestinal Oncology Specialists
Clinical Trials for Pancreatic Cancer
Because pancreatic cancer is so difficult to treat with standard therapies, clinical trials of new drugs and promising treatment combinations offer the most hope for patients. John Theurer Cancer Center conducts more clinical trials than any other cancer center in New Jersey. We also have a dedicated Phase I Clinical Trial Program, offering access to new treatments during their earliest stage of evaluation in patients. You may have the opportunity to participate in a clinical trial of an innovative therapy.Gastrointestinal Cancer Clinical Trials
You may also be interested in
The Research Division consolidates the basic and translational research and clinical trials that are conducted at John Theurer Cancer Center and the David Joseph Jurist Research Center for Tomorrows Children.